Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-11-06

Clinical Trial Update: IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating IH636 grape seed extract to treat radiation-induced fibrosis (hardening of breast tissue) in women who have undergone rad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IH636 Grape Seed Extract (grape seed extract)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Breast Cancer, Radiation Fibrosis | Phase 2 | Status: UNKNOWN